Apellis Pharmaceuticals, Inc. - Filer Information

Symbol
APLS on Nasdaq
Entity
Company
CIK
0001492422
EIN
271537290
Business address
100 Fifth Avenue, 02451 Waltham, MA
Phone
617-977-5700
State of incorporation
DE
Fiscal year end
December 31
Category
Large accelerated filer
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company